Drug resistance is a significant challenge in cancer therapy. Cancer cells can develop resistance through several mechanisms, including increased drug efflux via ATP-binding cassette transporters (e.g., P-glycoprotein), mutations in drug targets, activation of alternative signaling pathways, and enhanced DNA repair mechanisms. Understanding these resistance mechanisms is crucial for developing more effective treatments.
